Anti-PTK6 Antibody

PTK6, also known as BRK (Breast tumor kinase), is a non-receptor protein tyrosine kinase involved in signal transduction and oncogenic signaling pathways. This unconjugated polyclonal reagent, raised in Rabbit, recognizes human PTK6 and is validated for Western blot (WB) and immunohistochemistry (IHC) workflows.

The 200 µl volume provides enough material for multiple replicate experiments, including probing of lysates from mammary epithelial and carcinoma-derived cell models. The IgG isotype is compatible with standard secondary antibody reagents, and the unconjugated format gives flexibility in downstream reporter selection, including HRP, fluorophore, or biotin conjugates.

PTK6 expression has been characterized in normal epithelial tissues and is frequently elevated in HER2-positive tumors, supporting research on proliferation, differentiation, and tumor progression pathways. Supplied by Antibodies.com as a research use only reagent.